Battle of the Biomarkers of Systemic Inflammation
Systemic inflammation is monitored with various biomarkers; of these, C-reactive protein (CRP) is widely used due to its cost effectiveness and widespread implementation. However, its lack of specificity and delayed kinetics have directed interest in cell-free DNA (cfDNA), which offers rapid respons...
Saved in:
| Main Authors: | Emilia Stec-Martyna, Karolina Wojtczak, Dariusz Nowak, Robert Stawski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-7737/14/4/438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma
by: Ligia Gabriela Tataranu
Published: (2025-04-01) -
Liquid Biopsy-Based DNA Methylation Biomarkers for Precision Medicine in Breast Cancer
by: Ieva Sadzeviciene, et al.
Published: (2025-01-01) -
Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities
by: Birgit M. M. Wever, et al.
Published: (2025-07-01) -
Methylated ARHGAP40 DNA as a potential biomarker for early diagnosis in high-grade ovarian serous cancer
by: Jiaxin Chai, et al.
Published: (2025-07-01) -
Advances in cfDNA research for pregnancy-related diseases
by: Yimei Meng, et al.
Published: (2025-08-01)